The classical model of gene regulation by hormones involves a hormone-bound receptor interacting with a DNA response element to increase or decrease gene transcription. Steroid hormone regulation more commonly involves atypical cis-elements, co-receptors, accessory proteins, and unique modes of interaction on different genes. The thyroid hormone and retinoic acid receptors belong to the super family of steroid nuclear receptors and may modify gene expression even in the absence of ligand binding. In these studies, we characterized thyroid receptor-and retinoic acid receptor-mediated regulation of ␤1 adrenergic receptor (␤1AR) gene expression. Using cloned fragments of the ovine ␤1AR in a luciferase reporter vector, we examined the effects of thyroid receptor and retinoic acid receptor, alone and in combination with T3 or retinoic acid on ␤1AR expression. We examined expression in SK-N-SH neuroblastoma cells, CV-1 fibroblasts, and, in neonatal rat, primary cardiomyocytes. We demonstrated that even in the absence of ligand binding, thyroid receptor and retinoic acid receptor can significantly increase ␤1AR transcription activity. This effect is important in the developmental transition in ␤1AR expression during fetal and postnatal life. The classical model of gene regulation by hormones involves a hormone-bound receptor interacting with a DNA response element to increase or decrease gene transcription (1, 2). It is now appreciated that this model of hormonal regulation of gene expression is simplistic and may be the exception rather than the rule. For instance, classical models cannot explain the hormonal regulation of genes that lack canonical consensus DNA elements. These models also do not account for changes in hormonal regulation of gene expression at different developmental stages, differential regulation in different tissues, and other complexities of hormonal regulation. Steroid hormone regulation more commonly involves atypical cis-elements, co-receptors, accessory proteins, and unique modes of interaction on different genes (3).
The classical model of gene regulation by hormones involves a hormone-bound receptor interacting with a DNA response element to increase or decrease gene transcription (1, 2) . It is now appreciated that this model of hormonal regulation of gene expression is simplistic and may be the exception rather than the rule. For instance, classical models cannot explain the hormonal regulation of genes that lack canonical consensus DNA elements. These models also do not account for changes in hormonal regulation of gene expression at different developmental stages, differential regulation in different tissues, and other complexities of hormonal regulation. Steroid hormone regulation more commonly involves atypical cis-elements, co-receptors, accessory proteins, and unique modes of interaction on different genes (3).
The TR and RAR belong to the super family of steroid nuclear receptors (1) (2) (3) (4) . TR and RAR bind to DNA as heterodimers with RXR (4) . There is also a family of coregulators that positively and negatively regulate transcriptional activation from a variety of cis-elements in specific genes. Recently, it has been recognized that modulation of gene expression by steroid nuclear receptors may be independent of ligand binding to the steroid receptor. TR can bind to DNA in the absence of its ligand (thyroid hormone) and can regulate transcription both positively and negatively from a variety of promoters (5) (6) (7) . Transactivation by TR in the absence of hormone can require cell-specific factors but may occur even with promoters that do not contain clearly defined TRE (8, 9) . Similar observations have been reported for RAR (10) . A precise physiologic context for nonligand-dependent regulation of transcription by these receptors has not been shown.
We are interested in the hormonal regulation of the ␤1 adrenergic receptor (␤1AR) during development (11) (12) (13) (14) (15) (16) (17) (18) . The ␤1AR is a member of the seven transmembrane domain, G-protein coupled receptor superfamily (19) . This large class of signaling molecules includes the receptors for catecholamines, neurotransmitters, hormones, chemotaxins, and special senses. The ␤1AR is most highly expressed in the heart, where it is the major ␤AR subtype (19, 20) . In contrast to the ␤2 adrenergic receptor (␤2AR) gene, which has been well characterized (21, 22) , less is known about the ␤1AR and its transcriptional regulation. The gene encoding the ␤1AR contains a TATA-less promoter and the transcription start site does not resemble an initiator element (16, 23) . Sequence analysis has identified several putative GRE and TRE in the human, rat, and ovine ␤1AR promoters (16, 24, 25) . An inverted cAMP response element has also recently been identified in the ovine ␤1 adrenergic receptor gene promoter (26) .
It is well established that ␤1AR expression in adult animals and humans is influenced by thyroid hormones (27) (28) (29) (30) (31) (32) . Studies from our group and others have shown that the ␤1AR is expressed during late fetal development in both rodents and sheep and coupled to important physiologic responses (11) (12) (13) (14) (15) (16) (17) (18) . Interestingly, thyroid hormone alone or in combination with corticosteroids does not further increase ␤1AR receptor expression or density during fetal or early postnatal development (17, 18, 33, 34) . This is in marked contrast to the studies in older animals and humans where thyroid hormones have clearly been shown to increase ␤1AR expression and the increase has been shown to be at the level of gene transcription (28) .
The purpose of the present studies was to characterize thyroid hormone and TR-mediated regulation of ␤1AR gene expression. Because of their importance in cardiac development and because they have been shown to have important co-regulatory effects on other genes, we also examined the role of retinoic acid and the retinoid receptor on ␤1AR expression (35) (36) (37) . We report here evidence for transcriptional regulation of the ␤1AR gene by TR and RAR. These data suggest several mechanisms to explain the developmental transition in ␤1AR expression during fetal and postnatal life.
METHODS
Cell lines and cell culture. Unless otherwise noted, all chemicals were obtained from Sigma Chemical and all cell culture reagents were obtained from GIBCO BRL. Several cell lines were considered for expression studies. Rat C-6 glioma cells have been used extensively as a model of pharmacologic regulation of adrenergic receptors (38, 39) . Likewise, human SK-N-SH neuroblastoma cells express adrenergic receptors and have been used for studies of pharmacologic regulation of ␤AR expression (26) . CV-1 cells are a green monkey kidney fibroblast cell line that do not express endogenous TR or RAR. In replacement studies, CV-1 cells have been used extensively to explore the role for nuclear hormone receptors, co-receptors, and co-activators in gene regulation (7, 10) . To verify the veracity of expression in nontransformed cells, primary cardiomyocytes were also studied. Rat cardiomyocytes express adrenergic receptors that mediate important physiologic and adaptive effects (40, 41) .
All cell lines were used in transient transfection assays to analyze the promoter constructs described below. We examined the effects of thyroid hormone alone and in combination with TR expression vectors. Because our results demonstrated unliganded transcriptional activation of the ␤1AR promoter and because similar results have been seen by other investigators for several of the nuclear hormone receptors, we also examined the effects of retinoic acid and a RAR expression vector on the transcriptional activation of the ␤1 promoter constructs.
The SK-N-SH cells were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum (FBS), 50 unit/mL penicillin G, and 50 g/mL streptomycin in a humidified 37°C incubator containing 5% CO 2 . The CV-1 cells were cultured in Minimal Essential Media plus glutamine, 10% FBS, 50 unit/mL penicillin G, and 50 g/mL streptomycin. For transfection experiments, the cells were plated in 24-well culture plates at 80,000 cells per well and allowed to grow to 60 -70% confluency. In most experiments, a total of 0.4 g of DNA (0.2 g individual ␤1AR plasmids or the empty pGL2 vector and 0.2 g of the steroid nuclear receptor vector or empty plasmid) along with 0.2 g RSV-CAT DNA were transfected. All cells except the CV-1 cells were maintained in media containing stripped sera during the transfection experiments. The CV-1 cells were well maintained without sera present during transfections.
Primary neonatal rat cardiomyocytes were harvested from 3-d-old Sprague-Dawley rat pups and prepared using commercially available reagents (Worthington Biochemicals, Freehold, NJ, U.S.A.). All studies were approved by the Institutional Animal Care and Use Committee. Rat cardiomyocytes were isolated with minor modifications of the manufacturer's recommendations (37) . Following isolation, the cardiomyocytes were plated at 250,000 cells/well in F-10 medium containing 10% FBS and allowed a 24 -36 h recovery period before any transfection experiments. Like the SK-N-SH cells, primary neonatal rat cardiomyocytes were maintained in media containing stripped sera during transfection experiments.
Plasmids, constructs, and vectors. The ovine ␤1AR gene was cloned and sequenced in our laboratory (16) . Nested deletion constructs of the promoter region ranging from the full length promoter (-2333 bp) to the point where the transcription start site was deleted were subcloned into a luciferase reporter vector (pGL2basic, Promega, Madison, WI, U.S.A.) as described previously (18, 26) . Expression vectors containing TR or RAR were co-transfected with the promoter or relevant deletion constructs. Expression vectors for the steroid nuclear receptors and co-activators were kindly supplied by Dr. William Chin (Harvard University).
Gene expression analysis. Transfections were carried out using Lipofectin (GIBCO-BRL). In preliminary experiments, the ratio of DNA to transfection reagent and the total amount of DNA used in transfection experiments with each cell line were varied over a wide range. In subsequent experiments, the optimal ratio was used. In primary cardiomyocytes, the efficiency of transfection with Lipofectin was low. Noah et al. (42) have reported that the optimal transfection efficiency of primary cardiomyocytes was seen with Fugene 6 (Roche Molec-576 ular Biochemical, Summerville, NJ, U.S.A.). In preliminary studies, we demonstrated 5-to 10-fold greater efficiency of transfection for primary cardiomyocytes with Fugene 6 that was optimized and used in all subsequent experiments with these cells. After transfection, all cells were allowed to express for 16 -20 h and then the cells were washed and treated with either vehicle (2.5 M NaOH) or 100 nM thyroid hormone (T3) for an additional 24 h. In experiments using retinoic acid, the cells were washed and treated with either vehicle (0.01% DMSO) or 1 M retinoic acid (RA). Empty vector alone and vehicle controls were included in all experiments. An RSV-CAT construct under the control of a strong eukaryotic promoter was included in all experiments to control for transfection efficiency. Transcription activity was determined on cell lysates by assay of luciferase and CAT as described previously (18) . Activity was expressed relative to control conditions and/or empty vector after correction for transfection efficiency. Results are presented as mean Ϯ SEM and represent the average of two to three experiments carried out in quadruplicate.
RESULTS
Prior studies in our laboratory suggested that T3 alone or in combination with dexamethasone did not increase transcription activity of the ␤1AR promoter construct in C6 cells (18) . The lack of thyroid responsiveness could be due to low levels of expression of endogenous TR in the cell lines used or absence of co-regulators for thyroid responsiveness. We have used SK-N-SH neuroblastoma cells, which express ␤1AR, for transcription studies extensively (18, 26) . We therefore examined the effects of co-expression of TR with the ␤1AR promoter in this cell line. Co-transfection of the TR␤ with the full-length ␤1AR promoter was associated with a significant increase in gene expression (Fig. 1) . The addition of T3 decreased rather than increased transcriptional activation. These findings are consistent with so-called "unliganded" receptor-mediated activation. Unliganded transcriptional activation has been reported in a number of cell lines and with several different promoter constructs. Further, the reduction in transcriptional activity after the addition of T3 is consistent with the presence of a "negative" element. Figure 1 also shows in SK-N-SH cells that TR␤, not TR␣, increased transcriptional activity, even if unliganded. This is not surprising as TR␤ has been suggested by other investigations to have a more important physiologic role. In data not shown, we examined the effects of co-expression of TR in C6 cells and observed no effect of TR alone or in combination with thyroid hormone.
Transcriptional activation by unliganded steroid nuclear receptors may involve a variety of co-activators and coreceptors. We next examined the co-expression of TR and ␤1AR in CV-1 cells that lack endogenous steroid nuclear receptors and have been used extensively for recombination studies of nuclear receptor transactivation. As can be seen in Figure 2A , co-transfection of TR␤ alone was associated with a 5-fold increase in ␤1AR transcription activity in CV-1 cells. The addition of T3 had no further effect on activity. Recent studies have suggested unliganded transcriptional activation may involve other steroid nuclear receptors (10) . To examine this question, we co-transfected RAR with the ␤1AR construct alone and with concomitant treatment with retinoic acid. Similar to transfection with TR␤, co-transfection of RAR alone increased ␤1AR promoter activity by more than 10-fold. Treatment with retinoic acid decreased this effect by Ͼ60% (Fig.  2A) . Recent studies also suggest cross-talk among the steroid nuclear receptors (10) . In some instances, these interactions are stimulatory and in others result in repression of gene transcription. To examine the effects of other steroid nuclear receptors on the unliganded actions of TR␤, we transfected the ␤1AR promoter alone and in combination with TR␤, RAR, RXR, and glucocorticoid receptor. We also examined the effects of coexpression of TR␤ with TRAM or SRC, two important coactivators for TR-dependent regulation in some systems (43) . The results are shown in Figure 2B . Co-expression of TR␤ with RAR attenuated the effects of RAR alone (7-fold versus 10-fold) on ␤1AR promoter activity. Co-expression of RXR, glucocorticoid receptor (GR), SRC, or TRAM significantly attenuated the unliganded effects of TR␤ on ␤1AR activity in this expression system.
To examine whether the effects of unliganded thyroid receptor were due to use of transformed cell lines, the effect of TR alone and in combination with thyroid hormone on the ␤1AR promoter was examined in primary neonatal rat cardiomyocytes. Rat primary cardiomyocytes were transfected with ␤1AR in combination with either vehicle, TR␤ alone or TR␤ plus T3. As illustrated in Figure 3 , there was a significant increase in ␤1AR luciferase activity after transfection with TR␤ alone, consistent with unliganded hormone receptor transactivation. This activity was returned to nearly control levels when thyroid hormone was added.
The effects of unliganded nuclear receptors on gene regulation may be localized to discrete DNA elements or may be indirect via interaction with other transcription factors operating on other DNA elements (5-9). The precise cis-elements mediating negative regulation by thyroid hormones have not been well characterized in any genes. Therefore, to identify potential elements mediating the effect of unliganded receptor and to examine if the negative regulation mapped to a discrete area, neonatal rat cardiomyocytes were transfected with deletion constructs of the ␤1AR promoter and treated with either T3 alone, TR␤ alone, or TR␤ plus T3. Data for luciferase activity are expressed as the percentage of the vehicle control. The constructs are depicted in the legend of Figure 4 . As was seen earlier with the full-length, 2333-bp construct, co-transfection of TR␤ resulted in a significant increase in transcription activity. Treatment with T3 reduced this effect by Ͼ50%. As shown in the figure, deletion of sequences between -2333 and -2030 resulted in a reduction in the magnitude of the effect of unliganded activation but the increase with TR␤ alone was still nearly 2-fold greater than the control. Addition of T3 still resulted in a 50% reduction in transcription activity, suggesting that this fragment retained the suppressive activity associated with addition of thyroid hormone. These effects were not seen in the next deletion mutant or any of the other constructs. We performed a computer search for potential cis-elements on the sequences upstream from -1890 as well as across the full-length promoter using multiple transcription factor databases (44) . No canonical TRE or half-sites for TR binding were observed using any of the transcription factor matrices. In addition, we performed DNA footprinting using nuclear protein extracted from isolated cardiomyocytes. We did not see any protected regions across this stretch of sequence (not shown).
Because of their importance in early cardiac embryogenesis and later cardiac growth and development (35) (36) (37) , and because RAR and RA have been shown to mimic the unliganded effects of TR and T3 on relevant genes like preprothyrotropin releasing hormone (preproTRH) (10), we examined the effects of RAR and RA on ␤1AR expression in primary cardiomyocytes. The ␤1AR was transfected alone or in combination with RAR and treatment with RA. The results are shown in Figure  5 . Co-transfection of RAR resulted in a modest increase in 
578
␤1AR transcription that was not affected by co-treatment with all trans RA. When similar experiments were carried out with the nested deletions, this effect again mapped to the distal 5' region of the promoter.
DISCUSSION
The purpose of these experiments was to identify mechanisms involved in the developmental regulation of ␤1AR gene expression. Our data show that the ovine ␤1AR promoter contains sequences that mediate activation by unliganded TR as well as evidence for suppression of that activity by thyroid hormone. It is not clear if the same sequences are involved in both. The deletion analysis suggests sequences upstream from the proximal promoter are important in the nonligand-dependent activity of the TR. That interaction may involve regulatory sites other than TRE (e.g. AP-1). Unliganded trans-activation of the "full-length" ␤1AR promoter was also seen with the RAR and the addition of RA also decreased the level of transcription.
Over the last several years, a complex picture of the molecular mechanisms involved in thyroid hormone regulation of gene expression has emerged. The mechanisms involved are much more complicated than the classical model whereby thyroid hormone enters the nucleus, binds with its receptor, dimerizes with retinoid X receptor, and interacts with a canonical TRE in the DNA to affect gene expression (1) (2) (3) (4) . Of interest in our experiments is the finding that the TR appears to regulate ␤1AR gene expression even in the absence of ligand. Prior investigations have demonstrated similar effects on other genes (5-9). The ability of unliganded TR to both positively and negatively affect gene transcription is indicative of the complex mechanisms of hormonal regulation of gene expression. Fondell et al. (6) showed that unliganded TR can act as an active transcription repressor in HeLa cells. Samuels et al. (8) demonstrated that TR, in the absence of thyroid hormone, increased transactivation via TRE in the rat GH and prolactin gene promoters but only in specific cell types. Negative regulation of gene expression by steroid receptors is particularly complex. It is dependent on the gene, the cellular context, and the presence or absence of specific co-activators. In the case of the preproTRH gene, TR alone increases expression of reporter constructs that contain the proximal promoter (7). Addition of thyroid hormone results in a marked repression of this transactivation. Further, this effect is augmented by interaction with other nuclear receptors (7) .
Adrenergic receptor regulation may be "homologous," as in the case of down-regulation in response to chronic agonist exposure. There is also "heterologous" regulation of adrenergic receptors by nonligand factors such as hormones. Thyroid physiology and receptor occupancy are unique during the perinatal period. The expression of specific thyroid monodeiodinases during intrauterine life converts T4 to reverse T3. Reverse T3 does not bind to nuclear receptors and thus lacks the genomic effects of thyroid hormone. This results in low levels of thyroid hormone in utero in sheep and humans and also in rodents until the postnatal maturation of their thyroid axis (45) . The nuclear receptors for thyroid hormones in both rat and sheep are expressed at increasing levels during the latter part of gestation (45) (46) (47) . Interestingly, there is a low level of TR occupancy in rats until the second postnatal week (46) . Whereas the ␤1AR is expressed and coupled to important physiologic responses, thyroid hormone alone or in combination with corticosteroids does not increase ␤1AR receptor expression or density during fetal or early postnatal development (17, 33, 34) . This is in contrast to studies in older animals and humans where thyroid hormones have clearly been shown to increase ␤1AR expression (28) . Our data demonstrating that unliganded TR up-regulates ␤1AR gene expression suggest that unliganded TR stimulation contributes to a constitutively high level of ␤1AR transcription during late fetal and early neonatal life. This in turn contributes to a high level of ␤1AR density at a time when the fetus and newborn are uniquely dependent on sympathetic mechanisms for physiologic adaptation and survival.
Several nuclear receptors other than TR exhibit similar, complex, unliganded effects on transcriptional regulation. Retinoic acid up-regulates the preproTRH gene via an unliganded RAR-RXR mediated mechanism that does not require direct interaction with discrete DNA elements (10) . Similarly, transcriptional repression of the ␣ subunit of the pituitary glycoprotein hormones LH and FSH by the AR also occurs independent of direct DNA binding (48) . The mechanism of repression requires the DNA binding and ligand binding domains of the receptor, which interact with non-AR elements in the promoter including a cAMP regulatory element. The effects are important for ␣ subunit gene expression in gonadotropes. The orphan receptor CAR-␤ binds to DNA as a heterodimer with RXR and activates gene transcription constitutively in the absence of ligand (49) . This transactivation is dependent on the recruitment of transcriptional co-activators. As has been demonstrated for thyroid-and RA-mediated repression of prepro-TRH, androstane ligands for CAR-␤ repress transcriptional activation. They do so by promoting release of co-activators from the ligand binding domain (49) .
Also important, though not explored as completely as the metabolism of thyroid hormones, is the role of RA in cardiac development in utero. RA, RA binding proteins, and RAR are all important in embryogenesis (35) . Because of their importance in cardiac development (36) and because of the significant cross-talk seen with TR and RAR in regulation of other genes (10, 50), we examined the effect of RAR on regulation of ␤1AR. We demonstrated a significant increase in ␤1AR transcription by unliganded RAR. This is particularly germane to cardiac development where the ␤1AR is most highly expressed. Although the relative level of occupancy of RAR in utero is not known, fetal RA levels are substantially lower than maternal levels at all ranges of concentration (50) . Cardiac growth and development are affected importantly by alterations in RA homeostasis (51) . Thus, it is likely that RAR-dependent mechanisms, even in the face of reduced fetal RA levels and reduced receptor occupancy, contribute to constitutive expression of ␤1AR during development. The ␤1AR, in turn, is critically involved in cardiomyocyte proliferation during the fetal and early postnatal period and cardiac growth in later developmental periods (19, 52, 53) .
Steroid receptor-mediated regulation of gene expression is complex. The levels of complexity contribute to diversity in modes of regulation and allow for potential explanations for the tissue-specific, cell-specific, developmental stage-specific, 579 UNLIGANDED STEROID HORMONE REGULATION and ligand-dependent and -independent modes of gene expression. In these studies, we showed that unliganded TR and RAR exert important positive transcriptional effects on expression of the ␤1AR promoter. These effects may be particularly important in the context of a developmental period when occupancy of the thyroid nuclear receptor is low and dependence on ␤1AR-mediated mechanisms are critical for survival.
